We are live on ! Find out more
SGRY icon

Surgery Partners

182 hedge funds and large institutions have $3B invested in Surgery Partners in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 69 increasing their positions, 56 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 56

2.95% more ownership

Funds ownership: 108.45%111.39% (+2.9%)

6% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 34

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1% less funds holding

Funds holding: 183182 (-1)

33% less capital invested

Capital invested by funds: $4.44B → $3B (-$1.45B)

39% less call options, than puts

Call options by funds: $9.06M | Put options by funds: $14.8M

Holders
182
Holders Change
-1
Holders Change %
-0.55%
% of All Funds
2.4%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
36
Increased
69
Reduced
56
Closed
34
Calls
$9.06M
Puts
$14.8M
Net Calls
-$5.73M
Net Calls Change
+$4.66M
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
76
Wells Fargo
California
$1.21M +$20.5K +783 +1%
Citadel Advisors
77
Citadel Advisors
Florida
$1.13M +$1.16M +44,036 +472%
NIG
78
NFJ Investment Group
Texas
$1.1M -$16.6K -632 -1%
MCM
79
Moore Capital Management
New York
$1.06M
Principal Financial Group
80
Principal Financial Group
Iowa
$1.05M +$105K +3,997 +9%
MIM
81
MetLife Investment Management
New Jersey
$996K +$70.4K +2,684 +6%
VI
82
Versor Investments
New York
$978K +$992K +37,800 +450%
CSS
83
Cubist Systematic Strategies
Connecticut
$967K +$1.2M +45,677 New
Manulife (Manufacturers Life Insurance)
84
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$929K -$18.3K -699 -2%
Mirae Asset Global ETFs Holdings
85
Mirae Asset Global ETFs Holdings
Hong Kong
$925K +$43K +1,640 +4%
SEI Investments
86
SEI Investments
Pennsylvania
$924K +$140K +5,333 +14%
Two Sigma Investments
87
Two Sigma Investments
New York
$917K +$550K +20,949 +94%
WB
88
WesBanco Bank
West Virginia
$833K
CF
89
Corebridge Financial
Texas
$808K -$75.6K -2,882 -7%
Tudor Investment Corp
90
Tudor Investment Corp
Connecticut
$740K +$917K +34,954 New
Envestnet Asset Management
91
Envestnet Asset Management
Illinois
$692K +$130K +4,954 +18%
IIM
92
INTECH Investment Management
Florida
$660K +$307K +11,697 +60%
SA
93
Sanctuary Advisors
Indiana
$638K +$140K +5,351 +28%
NMC
94
Nine Masts Capital
Hong Kong
$606K +$752K +28,648 New
MFG
95
MidWestOne Financial Group
Iowa
$592K -$1.19M -45,518 -62%
HSBC Holdings
96
HSBC Holdings
United Kingdom
$574K -$116K -4,425 -14%
Ameriprise
97
Ameriprise
Minnesota
$562K -$29.7M -1,130,618 -98%
MS
98
Maven Securities
Jersey
$529K +$656K +25,000 New
Pathstone Holdings
99
Pathstone Holdings
New Jersey
$526K -$853K -32,514 -57%
Group One Trading
100
Group One Trading
Illinois
$526K +$621K +23,656 +2,015%

SGRY Hedge Fund Activity: Q4 2024 in Review

182 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q4 2024, worth a combined $3B — down 33% from $4.44B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new SGRY positions and 34 closed out — a net gain of 2 holders — while 69 added to existing stakes and 56 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $159M. The largest seller was Wellington Management Group, cutting an estimated $103M.

  • 182 institutional investors held Surgery Partners (SGRY) as of Q4 2024, down from 183 in Q3 2024.
  • Funds reported $3B of Surgery Partners stock for Q4 2024, down 33% quarter-over-quarter.
  • 36 funds opened new Surgery Partners positions in Q4 2024 and 34 closed out, a net change of +2 holders.
  • The largest Surgery Partners buyer in Q4 2024 was Janus Henderson Group, an estimated $159M added.
  • The largest Surgery Partners seller in Q4 2024 was Wellington Management Group, an estimated $103M sold.

Based on aggregated 13F filings for Q4 2024.